메뉴 건너뛰기




Volumn 21, Issue 4, 2012, Pages 515-522

Tedizolid (TR-701): A new oxazolidinone with enhanced potency

Author keywords

Oxazolidinone; Skin and skin structure infections; Staphylococcus aureus; Tedizolid

Indexed keywords

LINEZOLID; OXACILLIN; TEDIZOLID; VANCOMYCIN;

EID: 84858166133     PISSN: 13543784     EISSN: 17447658     Source Type: Journal    
DOI: 10.1517/13543784.2012.660250     Document Type: Article
Times cited : (64)

References (47)
  • 1
    • 0023808730 scopus 로고
    • Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium
    • Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-61
    • (1988) N Engl J Med , vol.319 , pp. 157-161
    • Leclercq, R.1    Derlot, E.2    Duval, J.3    Courvalin, P.4
  • 3
    • 0036735035 scopus 로고    scopus 로고
    • First outbreak of vancomycin-resistant enterococci in a tertiary hospital in Turkey
    • Colak D, Naas T, Gunseren F, et al. First outbreak of vancomycin-resistant enterococci in a tertiary hospital in Turkey. J Antimicrob Chemother 2002;50:397-401
    • (2002) J Antimicrob Chemother , vol.50 , pp. 397-401
    • Colak, D.1    Naas, T.2    Gunseren, F.3
  • 4
    • 0033252628 scopus 로고    scopus 로고
    • Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: Persistence of multiple species and multiple clones
    • Hsueh PR, Teng LJ, Pan HJ, et al. Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: persistence of multiple species and multiple clones. Infect Control Hosp Epidemiol 1999;20:828-33
    • (1999) Infect Control Hosp Epidemiol , vol.20 , pp. 828-833
    • Hsueh, P.R.1    Teng, L.J.2    Pan, H.J.3
  • 5
    • 58849090457 scopus 로고    scopus 로고
    • Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006
    • Ramsey AM, Zilberberg MD. Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol 2009;30:184-6
    • (2009) Infect Control Hosp Epidemiol , vol.30 , pp. 184-186
    • Ramsey, A.M.1    Zilberberg, M.D.2
  • 6
    • 0035666687 scopus 로고    scopus 로고
    • System Report Data summary from January 1992-June 2001, issued August 2001
    • National Nosocomial Infections Surveillance (NNIS)
    • National Nosocomial Infections Surveillance (NNIS) System Report, Data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001;29:404-21
    • (2001) Am J Infect Control , vol.29 , pp. 404-421
  • 7
    • 0034787718 scopus 로고    scopus 로고
    • Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study
    • DOI 10.1128/JCM.39.10.3727-3732.2001
    • Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 2001;39:3727-32 (Pubitemid 32954532)
    • (2001) Journal of Clinical Microbiology , vol.39 , Issue.10 , pp. 3727-3732
    • Fluit, A.C.1    Wielders, C.L.C.2    Verhoef, J.3    Schmitz, F.-J.4
  • 9
    • 18044365653 scopus 로고    scopus 로고
    • Community-acquired meticillin-resistant Staphylococcus aureus: An emerging threat
    • DOI 10.1016/S1473-3099(05)70112-2
    • Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005;5:275-86 (Pubitemid 40602247)
    • (2005) Lancet Infectious Diseases , vol.5 , Issue.5 , pp. 275-286
    • Zetola, N.1    Francis, J.S.2    Nuermberger, E.L.3    Bishai, W.R.4
  • 10
    • 20144386837 scopus 로고    scopus 로고
    • Methicillin-resistant Staphylococcus aureus disease in three communities
    • Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-44
    • (2005) N Engl J Med , vol.352 , pp. 1436-1444
    • Fridkin, S.K.1    Hageman, J.C.2    Morrison, M.3
  • 13
    • 77953265046 scopus 로고    scopus 로고
    • Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit
    • Sanchez Garcia M, De la Torre MA, Morales G, et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA 2010;303:2260-4
    • (2010) JAMA , vol.303 , pp. 2260-4
    • Sanchez Garcia, M.1    De La Torre, M.A.2    Morales, G.3
  • 14
    • 67649531477 scopus 로고    scopus 로고
    • Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia
    • Jacobson LM, Milstone AM, Zenilman J, et al. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia. Pediatr Infect Dis J 2009;28:445-7
    • (2009) Pediatr Infect Dis J , vol.28 , pp. 445-447
    • Jacobson, L.M.1    Milstone, A.M.2    Zenilman, J.3
  • 15
    • 15744365907 scopus 로고    scopus 로고
    • Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia
    • DOI 10.1086/428616
    • Mangili A, Bica I, Snydman DR, Hamer DH. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2005;40:1058-60 (Pubitemid 40418318)
    • (2005) Clinical Infectious Diseases , vol.40 , Issue.7 , pp. 1058-1060
    • Mangili, A.1    Bica, I.2    Snydman, D.R.3    Hamer, D.H.4
  • 16
    • 79956086972 scopus 로고    scopus 로고
    • Emergence of daptomycin resistance following vancomycin-unresponsive staphylococcus aureus bacteraemia in a daptomycin-naive patient-a review of the literature
    • van Hal SJ, Paterson DL, Gosbell IB. Emergence of daptomycin resistance following vancomycin-unresponsive staphylococcus aureus bacteraemia in a daptomycin-naive patient-a review of the literature. Eur J Clin Microbiol Infect Dis 2011;30:603-10
    • (2011) Eur J Clin Microbiol Infect Dis , vol.30 , pp. 603-610
    • Van Hal, S.J.1    Paterson, D.L.2    Gosbell, I.B.3
  • 18
    • 0034537258 scopus 로고    scopus 로고
    • Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections
    • PII S0924857900003034
    • Moise PA, Schentag JJ. Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections. Int J Antimicrob Agents 2000;16(Suppl 1):S31-4 (Pubitemid 32007934)
    • (2000) International Journal of Antimicrobial Agents , vol.16 , Issue.SUPPL. 1
    • Moise, P.A.1    Schentag, J.J.2
  • 19
    • 2942558870 scopus 로고    scopus 로고
    • Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
    • DOI 10.1128/JCM.42.6.2398-2402.2004
    • Sakoulas G, Moise-Broder PA, Schentag J, et al. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant staphylococcus aureus bacteremia. J Clin Microbiol 2004;42:2398-402 (Pubitemid 38747480)
    • (2004) Journal of Clinical Microbiology , vol.42 , Issue.6 , pp. 2398-2402
    • Sakoulas, G.1    Moise-Broder, P.A.2    Schentag, J.3    Forrest, A.4    Moellering Jr., R.C.5    Eliopoulos, G.M.6
  • 20
    • 43249095689 scopus 로고    scopus 로고
    • Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus
    • DOI 10.1016/S0924-8579(08)70002-5, PII S0924857908700025
    • Gould IM. Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus. Int J Antimicrob Agents 2008;31(Suppl(2):1-9 (Pubitemid 351657677)
    • (2008) International Journal of Antimicrobial Agents , vol.31 , Issue.SUPPL. 2 , pp. 1-9
    • Gould, I.M.1
  • 21
    • 0025279742 scopus 로고
    • Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users
    • Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 1990;34:1227-31 (Pubitemid 20177385)
    • (1990) Antimicrobial Agents and Chemotherapy , vol.34 , Issue.6 , pp. 1227-1231
    • Small, P.M.1    Chambers, H.F.2
  • 24
    • 0037458217 scopus 로고    scopus 로고
    • Linezolid: The first oxazolidinone antimicrobial
    • Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 2003;138:135-42
    • (2003) Ann Intern Med , vol.138 , pp. 135-142
    • Moellering, R.C.1
  • 26
    • 77951217660 scopus 로고    scopus 로고
    • Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain
    • Betriu C, Morales G, Rodriguez-Avial I, et al. Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain. Antimicrob Agents Chemother 2010;54:2212-15
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 2212-2215
    • Betriu, C.1    Morales, G.2    Rodriguez-Avial, I.3
  • 27
    • 77951234516 scopus 로고    scopus 로고
    • Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges
    • Brown SD, Traczewski MM. Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges. Antimicrob Agents Chemother 2010;54:2063-9
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 2063-9
    • Brown, S.D.1    Traczewski, M.M.2
  • 28
    • 67749127546 scopus 로고    scopus 로고
    • In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent
    • Schaadt R, Sweeney D, Shinabarger D, Zurenko G. In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent. Antimicrob Agents Chemother 2009;53:3236-9
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 3236-9
    • Schaadt, R.1    Sweeney, D.2    Shinabarger, D.3    Zurenko, G.4
  • 29
    • 78649681818 scopus 로고    scopus 로고
    • Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea
    • Yum JH, Choi SH, Yong D, et al. Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea. Antimicrob Agents Chemother 2010;54:5381-6
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 5381-6
    • Yum, J.H.1    Choi, S.H.2    Yong, D.3
  • 30
    • 62549099077 scopus 로고    scopus 로고
    • Activity of oxazolidinone TR-700 against linezolid-susceptible and-resistant staphylococci and enterococci
    • Livermore DM, Mushtaq S, Warner M, Woodford N. Activity of oxazolidinone TR-700 against linezolid-susceptible and-resistant staphylococci and enterococci. J Antimicrob Chemother 2009;63:713-15
    • (2009) J Antimicrob Chemother , vol.63 , pp. 713-715
    • Livermore, D.M.1    Mushtaq, S.2    Warner, M.3    Woodford, N.4
  • 31
    • 62549148632 scopus 로고    scopus 로고
    • TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens
    • Jones RN, Moet GJ, Sader HS, et al. TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens. J Antimicrob Chemother 2009;63:716-20
    • (2009) J Antimicrob Chemother , vol.63 , pp. 716-720
    • Jones, R.N.1    Moet, G.J.2    Sader, H.S.3
  • 32
    • 57049089598 scopus 로고    scopus 로고
    • In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains
    • Shaw KJ, Poppe S, Schaadt R, et al. In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains. Antimicrob Agents Chemother 2008;52:4442-7
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 4442-7
    • Shaw, K.J.1    Poppe, S.2    Schaadt, R.3
  • 34
    • 84858244397 scopus 로고    scopus 로고
    • In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci
    • Rodriguez-Avial I, Culebras E, Betriu C, et al. In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci. J Antimicrob Chemother 2012;67:167-9
    • (2012) J Antimicrob Chemother , vol.67 , pp. 167-169
    • Rodriguez-Avial, I.1    Culebras, E.2    Betriu, C.3
  • 35
    • 71249138911 scopus 로고    scopus 로고
    • Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700)
    • Locke JB, Hilgers M, Shaw KJ. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob Agents Chemother 2009;53:5265-74
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 5265-5274
    • Locke, J.B.1    Hilgers, M.2    Shaw, K.J.3
  • 36
    • 80051825841 scopus 로고    scopus 로고
    • Antivirulence potential of TR-700 and clindamycin on clinical isolates of Staphylococcus aureus producing phenol-soluble modulins
    • Yamaki J, Synold T, Wong-Beringer A. Antivirulence potential of TR-700 and clindamycin on clinical isolates of Staphylococcus aureus producing phenol-soluble modulins. Antimicrob Agents Chemother 2011;55:4432-5
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 4432-5
    • Yamaki, J.1    Synold, T.2    Wong-Beringer, A.3
  • 37
    • 78751689284 scopus 로고    scopus 로고
    • Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections
    • Prokocimer P, Bien P, Surber J, et al. Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections. Antimicrob Agents Chemother 2011;55:583-92
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 583-592
    • Prokocimer, P.1    Bien, P.2    Surber, J.3
  • 38
    • 79959194196 scopus 로고    scopus 로고
    • In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection model
    • Louie A, Liu W, Kulawy R, Drusano GL. In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection model. Antimicrob Agents Chemother 2011;55:3453-60
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 3453-3460
    • Louie, A.1    Liu, W.2    Kulawy, R.3    Drusano, G.L.4
  • 39
    • 79952280648 scopus 로고    scopus 로고
    • Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent
    • Im WB, Choi SH, Park JY, et al. Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent. Eur J Med Chem 2011;46:1027-39
    • (2011) Eur J Med Chem , vol.46 , pp. 1027-1039
    • Im, W.B.1    Choi, S.H.2    Park, J.Y.3
  • 43
    • 73949088615 scopus 로고    scopus 로고
    • Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): Studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines
    • Lemaire S, Van Bambeke F, Appelbaum PC, Tulkens PM. Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines. J Antimicrob Chemother 2009;64:1035-43
    • (2009) J Antimicrob Chemother , vol.64 , pp. 1035-1043
    • Lemaire, S.1    Van Bambeke, F.2    Appelbaum, P.C.3    Tulkens, P.M.4
  • 47
    • 33748192486 scopus 로고    scopus 로고
    • Linezolid for the treatment of patients with endocarditis: A systematic review of the published evidence
    • DOI 10.1093/jac/dkl219
    • Falagas ME, Manta KG, Ntziora F, Vardakas KZ. Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence. J Antimicrob Chemother 2006;58:273-80 (Pubitemid 44313381)
    • (2006) Journal of Antimicrobial Chemotherapy , vol.58 , Issue.2 , pp. 273-280
    • Falagas, M.E.1    Manta, K.G.2    Ntziora, F.3    Vardakas, K.Z.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.